a pharmaceutical composition for treating diabetes is provided in this invention . the composition contains a lanostane compound as a potent component . a suitable source of the lanostane compound is a poria extract from metabolite , sclerotium , or fermentation product of poria cocos wolf . the poria extract contains 1 - 60 % of the lanostane compounds by weight of the extract , and is devoid of secolanostane .